Comparison of losartan and captopril in ELITE II [1] (multiple letters)

Lancet

Volumn 356, Issue 9232, 2000, Pages 851-853

  Hall, Alistair ^a   Meyer, Frank P ^b   Gansevoort, R T ^c   Van Veldhuisen, D J ^c   Lye, Michael ^d   Pitt, Bertram ^e   Poole Wilson, Philip ^f  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF MICHIGAN   (United States)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOOP DIURETIC AGENT; LOSARTAN; ANTIARRHYTHMIC AGENT; ANGIOTENSIN RECEPTOR;

ADULT; AGED; AGING; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL ANALYSIS; SURVIVAL RATE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; NOTE; DRUG ANTAGONISM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; CAPTOPRIL; HEART FAILURE, CONGESTIVE; HUMANS; LOSARTAN; ADRENERGIC BETA-ANTAGONISTS; RECEPTORS, ANGIOTENSIN;

EID: 0034596512     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02667-2     Document Type: Letter

References (0)